[PDF] Top 20 Improving stroke prevention in patients with atrial fibrillation

... Whenever a message is shown, clicked, or ignored in the CDSS plugin, this event is stored in a database along with the current time and date. This will allow us to analyze the way the system is used by the GPs and will ... See full document

... Abstract: Atrial fibrillation (AF) is a common cardiac arrhythmia, especially in the elderly ...AF patients are first stratified into low, intermediate, and high risk for thromboembolic events using ... See full document

... Abstract: Atrial fibrillation (AF) is considered to be one of the most prevalent abnormal heart rhythm disorders and a leading cause of cerebral ...of stroke in AF is associ- ated with vascular risk ... See full document

... Atrial fibrillation occurs frequently in medical intensive care unit ...Whether atrial fibrillation contributes to morbidity and/or mortality and whether atrial fibrillation is ... See full document

... all patients, rural lo- cation, average years of experience, average years on the EMR, number of patients with hypertension, num- ber of patients with ischemic heart disease, number of ... See full document

... elderly patients ($60 years) with NVAF (mean age ...paroxysmal atrial fibrillation and non-paroxysmal atrial fibrillation (persistent or permanent) patients were ...1,000 ... See full document

... thromboembolic stroke in patients with chronic kidney disease (CKD) and atrial fibrillation (AF) treated with and without ...thromboembolic stroke and of major bleeding in 399 ... See full document

... of stroke, with an estimated annual cost of ...in patients with atrial ...and atrial fibrillation are recognized as strong risk factors for stroke, the basis for this ... See full document

... for atrial fibrillation (AF) in present treatment guidelines, practical, clinical antithrombotic therapy is poorly developed for very elderly ...consecutive patients with AF of mean age 85 years, to ... See full document

... all patients who have taken at least one dose of rivaroxaban, although analyses will be performed not only for the full study sample but also for each participating country where numbers are sufficient for ... See full document

... AF patients were selected if they compared at least two of the following: placebo, aspirin, aspirin and clopidogrel combination therapy, adjusted-dose warfarin (target international normalized ratio ...(all ... See full document

... and HR=4.03 (CI 2.31 to 7.02) for high versus low risk. In men, those having CHA 2 DS 2 -VASc <2 were further risk stratified by IMRS with fully adjusted HR=2.14 (CI 1.65 to 2.77) for moderate versus low risk and ... See full document

... of patients using anticoagulants was de- termined based on prescription claims with national drug codes ...(NDCs). Patients with at least one prescription claim for an anticoagulant medication were ... See full document

... in atrial fi brillation patients undergoing PCI has been shown to carry a higher risk of major bleeding compared to dual ...4614 patients were assigned to apixaban or vitamin K antagonist and aspirin ... See full document

... effective prevention of complications asso- ciated with AF ...AF patients should vary according to their risk status for stroke, defined by the CHADS2 (Car- diac failure, Hypertension, Age, Diabetes, ... See full document

... The interview consisted of four validated questionnaires - the 8-item Morisky Medication Adherence Scale (MMAS-8), Anticoagulant Knowledge Tool (AKT), Short Test of Functional Health Literacy in Adults (s-TOFHLA) and the ... See full document

... many patients from taking this ...for stroke prevention — without increasing the risk of bleeding — in patients with AF with increased stroke risk are ...left atrial appendage ... See full document

... left atrial appendage as the most import- ant source of cardiac thromboembolism related to AF has led to introduction of left atrial appendage occlusion (LAAO) into clinical practice as a potential ... See full document

... of Stroke Prevention in Atrial Fibrillation (SPAF) 15 , 1330 patients were followed for a mean period of ...years. Patients were randomised to two groups and those eligible (most ... See full document

... ACS patients was planned and then ...in patients with ACS on dual-antiplatelet therapy: a ran- domized, double-blind, Phase II trial (RE-DEEM) included patients after STEMI and non-ST elevation MI ... See full document